Using pharmacological inhibitors we demonstrate, that the NADPH oxidases and iNOS are the major sources of superoxide, and that cyclooxygenases may also modestly contribute to O2•− production in AAA. The gene discussed is FMO5; the disease is triple-A syndrome.